Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151.

Chiyomaru T, Yamamura S, Zaman MS, Majid S, Deng G, Shahryari V, Saini S, Hirata H, Ueno K, Chang I, Tanaka Y, Tabatabai ZL, Enokida H, Nakagawa M, Dahiya R.

PLoS One. 2012;7(8):e43812. doi: 10.1371/journal.pone.0043812. Epub 2012 Aug 23.

2.

Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.

Fuse M, Kojima S, Enokida H, Chiyomaru T, Yoshino H, Nohata N, Kinoshita T, Sakamoto S, Naya Y, Nakagawa M, Ichikawa T, Seki N.

J Hum Genet. 2012 Nov 26;57(11):691-9. doi: 10.1038/jhg.2012.95. Epub 2012 Aug 2.

PMID:
22854542
3.

Genistein affects histone modifications on Dickkopf-related protein 1 (DKK1) gene in SW480 human colon cancer cell line.

Wang H, Li Q, Chen H.

PLoS One. 2012;7(7):e40955. doi: 10.1371/journal.pone.0040955. Epub 2012 Jul 18.

4.

Cancer stem cells: potential target for bioactive food components.

Kim YS, Farrar W, Colburn NH, Milner JA.

J Nutr Biochem. 2012 Jul;23(7):691-8. doi: 10.1016/j.jnutbio.2012.03.002. Review.

5.

Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p.

Su Y, Ni Z, Wang G, Cui J, Wei C, Wang J, Yang Q, Xu Y, Li F.

Int Immunopharmacol. 2012 Aug;13(4):468-75. doi: 10.1016/j.intimp.2012.05.016. Epub 2012 Jun 7.

6.

GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics.

Tabas-Madrid D, Nogales-Cadenas R, Pascual-Montano A.

Nucleic Acids Res. 2012 Jul;40(Web Server issue):W478-83. doi: 10.1093/nar/gks402. Epub 2012 May 9.

7.

Isolation of miRNAs that target EGFR mRNA in human lung cancer.

Yamaguchi G, Takanashi M, Tanaka M, Fujita K, Ohira T, Kuroda M, Ikeda N.

Biochem Biophys Res Commun. 2012 Apr 6;420(2):411-6. doi: 10.1016/j.bbrc.2012.03.008. Epub 2012 Mar 9.

PMID:
22426479
8.

microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor.

Tao J, Wu D, Xu B, Qian W, Li P, Lu Q, Yin C, Zhang W.

Oncol Rep. 2012 Jun;27(6):1967-75. doi: 10.3892/or.2012.1711. Epub 2012 Mar 7.

PMID:
22407299
9.

Genomic sequence analysis of EGFR regulation by microRNAs in lung cancer.

Chan LW, Wang FF, Cho WC.

Curr Top Med Chem. 2012;12(8):920-6.

PMID:
22352917
10.

Up-regulation of microRNA-21 correlates with lower kidney cancer survival.

Zaman MS, Shahryari V, Deng G, Thamminana S, Saini S, Majid S, Chang I, Hirata H, Ueno K, Yamamura S, Singh K, Tanaka Y, Tabatabai ZL, Dahiya R.

PLoS One. 2012;7(2):e31060. doi: 10.1371/journal.pone.0031060. Epub 2012 Feb 8.

11.

Cancer statistics, 2012.

Siegel R, Naishadham D, Jemal A.

CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.

12.

Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines.

Tatarano S, Chiyomaru T, Kawakami K, Enokida H, Yoshino H, Hidaka H, Nohata N, Yamasaki T, Gotanda T, Tachiwada T, Seki N, Nakagawa M.

Int J Oncol. 2012 Apr;40(4):951-9. doi: 10.3892/ijo.2011.1294. Epub 2011 Dec 13.

13.

MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer.

Xu B, Wang N, Wang X, Tong N, Shao N, Tao J, Li P, Niu X, Feng N, Zhang L, Hua L, Wang Z, Chen M.

Prostate. 2012 Aug 1;72(11):1171-8. doi: 10.1002/pros.22466. Epub 2011 Dec 7.

PMID:
22161865
14.

Examining the role of Rac1 in tumor angiogenesis and growth: a clinically relevant RNAi-mediated approach.

Vader P, van der Meel R, Symons MH, Fens MH, Pieters E, Wilschut KJ, Storm G, Jarzabek M, Gallagher WM, Schiffelers RM, Byrne AT.

Angiogenesis. 2011 Dec;14(4):457-66. doi: 10.1007/s10456-011-9229-x. Epub 2011 Jul 26.

PMID:
21789714
15.

Genistein attenuates WNT signaling by up-regulating sFRP2 in a human colon cancer cell line.

Zhang Y, Chen H.

Exp Biol Med (Maywood). 2011 Jun 1;236(6):714-22. doi: 10.1258/ebm.2011.010347. Epub 2011 May 13.

PMID:
21571909
16.

miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer.

Tatarano S, Chiyomaru T, Kawakami K, Enokida H, Yoshino H, Hidaka H, Yamasaki T, Kawahara K, Nishiyama K, Seki N, Nakagawa M.

Int J Oncol. 2011 Jul;39(1):13-21. doi: 10.3892/ijo.2011.1012. Epub 2011 Apr 20.

PMID:
21519788
17.

Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells.

Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad A, Banerjee S, Azmi AS, Miele L, Sarkar FH.

Cancer Lett. 2011 Aug 1;307(1):26-36. doi: 10.1016/j.canlet.2011.03.012. Epub 2011 Apr 3.

18.

MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1.

Cho WC, Chow AS, Au JS.

RNA Biol. 2011 Jan-Feb;8(1):125-31. Epub 2011 Jan 1.

PMID:
21289483
19.

MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer.

Chen Y, Zaman MS, Deng G, Majid S, Saini S, Liu J, Tanaka Y, Dahiya R.

Cancer Prev Res (Phila). 2011 Jan;4(1):76-86. doi: 10.1158/1940-6207.CAPR-10-0167. Epub 2010 Nov 11.

20.

MicroRNA regulation of growth factor receptor signaling in human cancer cells.

Giles KM, Barker A, Zhang PM, Epis MR, Leedman PJ.

Methods Mol Biol. 2011;676:147-63. doi: 10.1007/978-1-60761-863-8_11.

PMID:
20931396

Supplemental Content

Support Center